Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Author :

Ki Tae Yoon, Hongqun Liu, Jing Zhang, Sojung Han, Samuel S. Lee

Clin Mol Hepatol. 2022;28(2):232-241. Published online January 5, 2022

DOI: https://doi.org/10.3350/cmh.2021.0141

View: 4710 Download: 107 Web of Science: 5 Crossref: 6

Ki Tae Yoon, Hongqun Liu, Samuel S. Lee

Clin Mol Hepatol. 2021;27(3):425-436. Published online December 3, 2020

DOI: https://doi.org/10.3350/cmh.2020.0234

View: 6328 Download: 268 Web of Science: 23 Crossref: 24

Moon Young Kim, Soon Koo Baik, Samuel S. Lee

Clin Mol Hepatol. 2010;16(4):347-352. Published online December 31, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.4.347

View: 10861 Download: 157 Crossref: 68

Samuel S. Lee

4 Articles

Viewed By 5484	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4643	MAFLD: How is it different from NAFLD?
Viewed By 4389	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3605	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3553	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 78	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 68	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Author index